Weekly Reports | Feb 14 2025
Our top ten news from 06 February 2025 to 13 February 2025 (ranked according to popularity).
1 – FNArena Corporate Results Monitor – 07-02-2025
Friday 07 February 2025
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
2 – FNArena Corporate Results Monitor – 06-02-2025
Thursday 06 February 2025
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
3 – Amcor Confident In Berry On Top
Friday 07 February 2025
Amcor posted a solid quarter but all eyes are on the company’s proposed takeover of the larger Berry Global Group
4 – Rudi’s View: AGL Energy, Bega Cheese, BRG, Harvey Norman, Imdex & Superloop
Thursday 06 February 2025
Updates on stock picker’s favourites and Model Portfolio adjustments
5 – FNArena Corporate Results Monitor – 10-02-2025
Monday 10 February 2025
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
6 – ESG Focus: Top ASX Companies, Superbugs & Hydrogen
Friday 07 February 2025
Addressing challenges and opportunities in meeting the UN Sustainable Development Goals and what ESG characteristics underpin share prices
7 – DeepSeek Fuels AI Technology Advances
Thursday 06 February 2025
The pace of artificial intelligence innovation was reinforced with DeepSeek and it’s all systems go with software and hardware working in combination
8 – The Market In Numbers – 8 Feb 2025
Saturday 08 February 2025
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
9 – FNArena Corporate Results Monitor – 11-02-2025
Tuesday 11 February 2025
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
10 – Behring Margin Outlook Still Main Game For CSL
Thursday 13 February 2025
A weak vaccine result dragged on CSL’s H1 result but analysts focus on an improving plasma product margin and solid growth forecasts in maintaining positive views